E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Zydus and MSN are the first companies to launch a generic version of Adempas (riociguat) in the US market.
imphoenix82
The development comes as Zydus continues to expand its portfolio of generic medicines in the US market.
imphoenix82
Zydus’ Desidustat received approval from the Drug Controller General of India (DCGI) in March 2022 for the treatment of anaemia in patients with chronic kidney disease (CKD).
imphoenix82
Zydus Lifesciences and Sunshine Healthcare have established a joint venture company to establish a pharma manufacturing facility in Sri Lanka.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
